| Product NDC: | 46287-014 |
| Proprietary Name: | Oracit |
| Non Proprietary Name: | Citric Acid and Sodium Citrate |
| Active Ingredient(s): | 640; 490 mg/5mL; mg/5mL & nbsp; Citric Acid and Sodium Citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 46287-014 |
| Labeler Name: | Carolina Medical Products Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 19840515 |
| Package NDC: | 46287-014-01 |
| Package Description: | 500 mL in 1 BOTTLE (46287-014-01) |
| NDC Code | 46287-014-01 |
| Proprietary Name | Oracit |
| Package Description | 500 mL in 1 BOTTLE (46287-014-01) |
| Product NDC | 46287-014 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Citric Acid and Sodium Citrate |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 19840515 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Carolina Medical Products Company |
| Substance Name | CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Strength Number | 640; 490 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |